Delivery Order SPE2DB22D3016-SPE2DB25FBEA5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of Aprepitant 80 mg capsules under a firm fixed-price contract with a ceiling value of $1,183.49. This delivery order, designated as a non-set-aside award, falls under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The funding agency is the DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,224.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Aprepitant 130mg/18ml (a chemotherapy-related nausea and vomiting preventative medication). This non-set-aside delivery order is expected to reach completion by September 8, 2025, with fulfillment taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,219.21 firm fixed-price delivery order is for APREPITANT 80 MG CAPSULE UD 6S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEA5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,693.94 to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules, unit dose, in quantities of six. This contract, which was competitively awarded with no set-aside designation, has a completion date of August 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order employs firm fixed price pricing and represents a continuation of the agency's pharmaceutical supply chain operations supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support globally to military healthcare programs, serving entities including the Defense Health Agency and U.S. Coast Guard. Aprepitant, an antiemetic medication commonly used in chemotherapy and post-operative care, represents the type of specialized pharmaceutical product routinely distributed through this strategic partnership to support federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/5/25 |